ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Elis.

Elis. (ELIS)

19.36
-0.38
(-1.93%)
Closed February 03 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
19.36
Bid
19.21
Ask
19.44
Volume
442,225
18.69 Day's Range 19.48
17.64 52 Week Range 23.58
Market Cap
Previous Close
19.74
Open
18.79
Last Trade
773
@
19.36
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
323,447
Shares Outstanding
235,567,817
Dividend Yield
2.22%
PE Ratio
17.38
Earnings Per Share (EPS)
1.11
Revenue
4.31B
Net Profit
262.4M

About Elis.

Sector
Management Consulting Svcs
Industry
Management Consulting Svcs
Headquarters
Saint-cloud, Hauts-de-seine, Fra
Founded
-
Elis. is listed in the Management Consulting Svcs sector of the Euronext with ticker ELIS. The last closing price for Elis was 19.74 €. Over the last year, Elis shares have traded in a share price range of 17.64 € to 23.58 €.

Elis currently has 235,567,817 shares outstanding. The market capitalization of Elis is 4.65 € billion. Elis has a price to earnings ratio (PE ratio) of 17.38.

ELIS Latest News

Elis : Chiffre d'affaires annuel 2024

Elis : Chiffre d'affaires annuel 2024 Chiffre d’affaires 2024 record à 4,57md€, en croissance de +6,1% vs. 2023 Résultats 2024 estimés en ligne avec nos objectifs : Marge d’EBITDA ajusté...

Elis: 2024 full-year revenue

Elis: 2024 full-year revenue Record revenue of €4.57bn in 2024, up +6.1% vs. 2023 Estimated 2024 financial results meet communicated targets: Adjusted EBITDA at c. 35.2%Free cash flow slightly...

Elis : Bilan semestriel du contrat de liquidité au 31 décembre 2024

Elis : Bilan semestriel du contrat de liquidité au 31 décembre 2024 Bilan semestriel du contrat de liquidité Au titre du contrat de liquidité confié par Elis à Oddo BHF (groupe Natixis), à la...

Elis: Half-yearly report relative to the liquidity contract as of 31 December 2024

Elis: Half-yearly report relative to the liquidity contract as of 31 December 2024 Half-yearly report relative to the liquidity contract Under the liquidity contract entered between Elis and Oddo...

Elis : Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 12 2024

Elis : Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 12 2024 DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS...

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 12 2024

Elis: Disclosure of the number of shares forming the capital and of the total number of voting rights as of 31 12 2024 DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE...

Elis annonce l’acquisition de Wäscherei Bodensee en Suisse

Elis annonce l’acquisition de Wäscherei Bodensee en Suisse Elis annonce l’acquisition de Wäscherei Bodensee en Suisse Saint-Cloud, le 10 janvier 2025 – Elis, leader mondial des services...

Elis announces the acquisition of Wäscherei Bodensee in Switzerland

Elis announces the acquisition of Wäscherei Bodensee in Switzerland Elis announces the acquisition of Wäscherei Bodensee in Switzerland Saint-Cloud, 10 January 2025 – Elis, the global leader in...

Elis poursuit la consolidation de son réseau en Allemagne avec l'acquisition de Ernst

Elis poursuit la consolidation de son réseau en Allemagne avec l'acquisition de Ernst Elis poursuit la consolidation de son réseau en Allemagne avec l’acquisition de Ernst Saint-Cloud, le 19...

Elis continues the consolidation of its network with the acquisition of Ernst in Germany

Elis continues the consolidation of its network with the acquisition of Ernst in Germany Elis continues the consolidation of its network with the acquisition of Ernst in Germany Saint-Cloud, 19...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.13-0.66700872242219.4920.418.6929195619.85856305DE
40.84.3103448275918.5620.418.2428406419.4823768DE
12-2.76-12.477396021722.1222.2418.2232344719.40504056DE
26-0.64-3.22023.2817.6439304919.90060493DE
52-1.2-5.8365758754920.5623.5817.6434421220.45639573DE
1562.8417.19128329316.5223.5810.2334578116.88630304DE
2601.79.6262740656917.6623.585.37539213415.06010489DE

ELIS - Frequently Asked Questions (FAQ)

What is the current Elis share price?
The current share price of Elis is 19.36 €
How many Elis shares are in issue?
Elis has 235,567,817 shares in issue
What is the market cap of Elis?
The market capitalisation of Elis is EUR 4.65B
What is the 1 year trading range for Elis share price?
Elis has traded in the range of 17.64 € to 23.58 € during the past year
What is the PE ratio of Elis?
The price to earnings ratio of Elis is 17.38
What is the cash to sales ratio of Elis?
The cash to sales ratio of Elis is 1.06
What is the reporting currency for Elis?
Elis reports financial results in EUR
What is the latest annual turnover for Elis?
The latest annual turnover of Elis is EUR 4.31B
What is the latest annual profit for Elis?
The latest annual profit of Elis is EUR 262.4M
What is the registered address of Elis?
The registered address for Elis is 5 BOULEVARD LOUIS LOUCHEUR, SAINT-CLOUD, HAUTS-DE-SEINE, 92210
What is the Elis website address?
The website address for Elis is www.corporate-elis.com
Which industry sector does Elis operate in?
Elis operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TUVDSBio UV Group DS
0.0562 €
(274.67%)
70.47k
ALORAAltheora
0.444 €
(30.97%)
51.59k
ALAGOEPango SA
0.285 €
(20.25%)
280.31k
ALMDTMedian Technologies
4.07 €
(16.29%)
59.58k
ALNEVNeovacs
0.2999 €
(15.35%)
13.84k
ALCYBCybergun
0.0001 €
(-50.00%)
30.69M
BIODSBiosynex DS
0.0401 €
(-42.71%)
107.26k
MLWEYWeya
0.016 €
(-40.74%)
7
GIM32Gimv NV
0.58 €
(-34.09%)
338.09k
CFNCofina SGPS SA
10.70 €
(-33.75%)
7.67k
ATOAtos SE
0.0021 €
(-8.70%)
277.95M
ALVERVergnet
0.001 €
(-9.09%)
23.1M
BCPBanco Comercial Portugues SA
0.4935 €
(-2.35%)
12.54M
ALCYBCybergun
0.0001 €
(-50.00%)
7.23M
KPNKoninklijke KPN NV
3.489 €
(-0.06%)
5.4M

Discussion

View Full Feed
Carjockey2 Carjockey2 2 minutes ago
I would charge you..lol

You said you have money..lol

>>> I'm living rent free in your head>>>

#4,401
HMBL
janice shell janice shell 2 minutes ago
Read this, too:

https://www.politico.com/news/2025/02/03/unions-sue-block-musk-treasury-payment-00202243
StayHumble StayHumble 3 minutes ago
Full Year Sales $55M+Up 90%💹 ✅GrossProfit $20M+Up 99%✅ 💹
https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results
https://investorshub.advfn.com/uimage/uploads/2025/1/30/wxltydownload.png
HCWC
yp_1 yp_1 3 minutes ago
June 30 2025 is approaching fast…https://www.newswire.ca/news-releases/ai-hyperscale-switch-manufacturer-confirms-market-leading-performance-of-spectra7-enabled-800g-active-copper-cables-868324598.html
SEV
Carjockey2 Carjockey2 4 minutes ago
LMAO

You need new material...

I've only heard that about a million times when one is skirting the questions.

Figure out my math problem yet??

😉😉😉😉😉😉😉😉

#4,401 l
HMBL
k9narc k9narc 6 minutes ago
I use the thermometer laser gun for the bath tub.

I'll get a fish tank for the sous vide.

https://investorshub.advfn.com/uimage/uploads/2025/2/3/vruyy466104054_529299336676584_2250637908224296262_n.jpg
branster branster 8 minutes ago
A PDF document I ran across called "Shorting Innovation" written by Nancy S. Kim from the Loyola of Los Angeles Law Review that has some very detailed history on @NorthwestBio dating back to 2011. This was published in Sept 2024. Below is the contents, the document has all sorts of interesting fa
NWBO
mick mick 8 minutes ago
RIPE TWIZZER CALL --- IF CORRECT 5 CENTS, confirmed today

www.stockta.com/cgi-bin/candle.pl?symb=cnrc&scale=log

[-chart]www.stockta.com/cgi-bin/candle.pl?symb=cnrc&scale=log
CNRC
janice shell janice shell 9 minutes ago
I subscribe to the Times digital but even they were playing the both sides game during the run up to the election.

You know, I took the word of reasonable Dem politicians and party officials who assured us the presidential election was honest, its results legitimate.

I
TenKay TenKay 10 minutes ago
I am living rent free in your head aren’t I….

🤣
HMBL
Brody30 Brody30 10 minutes ago
Hey guys what’s going on here I just saw the chart it looks amazing. New business coming into this $RITE?
RITE
jimr1717 jimr1717 11 minutes ago
There is no company. Sounds pretty correct to me
CRSM
kspar1 kspar1 12 minutes ago
Missling must have a new media presence manager... Love it. Gotta stir the pot, beat that drum and establish that Anavex is an emergent presence to consider. He's on a LinkedIn roll.
https://www.linkedin.com/posts/christopher-missling-phd-18924a_the-rising-cost-of-drug-development-in-healthc
AVXL
flipper44 flipper44 12 minutes ago
Theoretically, could long’s borrow shares but not sell them? In other words drain the supply?
NWBO
pos_stock_hoarder pos_stock_hoarder 13 minutes ago
Like NOTHING COMPARES 2 U sung by Sinead O'Conner!
JP313 JP313 13 minutes ago
You do know neither of you have been proven correct.
CRSM
CanItBThisEZ2Make CanItBThisEZ2Make 14 minutes ago
BEST SELLERS RANK (BSR) IS 342 32 Estimated Sold on Amazon Since JAN 1 - 1ST Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
goodietime goodietime 15 minutes ago
"sixteen plus years of this nonsense is enough!"

I totally agree. One of the problems is, nobody puts any kind of time limit on this. Most tasks take as much time as allowed. If this had to have been cleared up in 5 or 10 years, it would have been. But lawyers and FDIC workers decided
COOP
axelvento axelvento 15 minutes ago
Work finishes on Moderna Innovation and Technology Centre in Oxfordshire

Construction is now complete on the Moderna Innovation and Technology Centre (MITC), the pharma firm’s new research, development and manufacturing facility at Harwell Campus in Oxfordshire.

Subject
MRNA
MrMike241 MrMike241 16 minutes ago
Keep the Sous Vide for the bathtub 🛀🤔

Your Recent History

Delayed Upgrade Clock